Issue of Equity

RNS Number : 2266Q
Falanx Group Limited
25 November 2016
 

Falanx Group Limited

("Falanx" or "the Company")

 

Issue of Equity

 

Falanx Group (AIM:FLX) announces that, on 25 November 2016, the Company issued 625,000 new ordinary shares of no par value in the capital of the Company ("Ordinary Shares") as a result of the exercise of warrants. The warrants were exercised at a price of six pence per Ordinary Share pursuant to the terms of the warrant instrument issued by the Company on 5 May 2016 as previously notified.

Application has been made for the new Ordinary Shares to be admitted to trading on the AIM Market of the London Stock Exchange ("Admission"), which is expected to take place on or around 8.00a.m. on 1 December 2016. The new Ordinary Shares will, when issued, be credited as fully paid and rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

Following Admission, the Company's enlarged issued share capital will comprise 125,605,904 Ordinary Shares carrying one vote per share. The Company does not hold any Ordinary Shares in treasury.

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive

 

 

 

via Walbrook PR

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

Panmure Gordon (UK) Limited

Nominated Adviser & Joint Broker

Andrew Godber / Peter Steel

 

+44 (0) 20 7886 2500

Whitman Howard Limited

Joint Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

Walbrook PR (Media and Investor Relations) Paul Cornelius / Nick Rome

+44 (0) 207 933 8780

falanx@walbrookpr.com

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEDELFLQFFBFBK
UK 100

Latest directors dealings